Q&A ILCA Systemic Therapy Guidance

    Sunday, September 13, 2020: 4:35 PM - 4:50 PM


    R.Kate Kelley
    Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
    Tim Meyer
    Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals. ILCA Communication Committee Chair.


    The past few years have witnessed huge progress in the treatment of advanced HCC and the therapeutic landscape has been transformed. In order to provide comprehensive, up-to-date and readily accessible information about the latest treatment, ILCA have developed on-line guidance. The guidance will be launched at the ILCA 2020 conference during which Tim Meyer and Katie Kelley will present the key features which will include:

    1.           Interactive therapeutic algorithm

    2.           Summary of and links to key data that provide the evidence base for current therapy

    3.           Focussed discussion on clinical decision making according to specific clinical contexts

    15 minutes Q&A with speakers. Participants will be able to ask questions in writing using a Q&A box.

    The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html

    Super Track(s)